Chief scientific officer, Bruce Hillman, M.D., FACR, of ACR Image Metrix, presented this issue, Methodologic Considerations in Designing Pharmaceutical Trials Using Novel Imaging Strategies. Scientific director of ACR Image Metrix’ imaging primary laboratory, Mehdi Adineh, Ph.D., presented Increasing the potency of Novel Imaging in Clinical Trials: The Role of the Imaging Core Laboartory. Greg Sorenson, M.D., professor of radiology at Harvard Medical College, Massachusetts General Hospital, also presented his topic, Mechanistic Imaging in Malignancy Trials: Lessons from Glioblastoma. We [ACR Picture Metrix] are the industry innovator in global imaging trials, mentioned Dr. Hillman. Our time help with, dedication and determination, study and information gain access to paves just how for creativity and drives the future of imaging in scientific trials.In addition to its powerful, schedule based service delivery element, AcceliTRACK integrates fully with AcceliPLAN a robust, simple to use, IEP development and compliance device. This service is being supplied at 5 percent of paid claims without out of pocket costs to the district. Related StoriesUsing integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya DasAddressing quality of life needs in prostate tumor: an interview with Professor Louis DenisDeaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHMEAcceliPLAN – – Accelify’s robust IEP advancement tool that integrates directly with the AcceliTRACK program billing and compliance plan has been released for school districts in the State of Missouri.